AAAAAA

   
Results: 1-17 |
Results: 17
Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments
Authors: Dowjat, WK Wisniewski, H Wisniewski, T
Citation: Wk. Dowjat et al., Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments, NEUROSCIENC, 103(1), 2001, pp. 1-8
Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie
Authors: Aucouturier, P Geissmann, F Damotte, D Saborio, GP Meeker, HC Kascsak, R Kascsak, R Carp, RI Wisniewski, T
Citation: P. Aucouturier et al., Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie, J CLIN INV, 108(5), 2001, pp. 703-708
Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A beta peptide
Authors: Poeggeler, B Miravalle, L Zagorski, MG Wisniewski, T Chyan, YJ Zhang, YB Shao, HY Bryant-Thomas, T Vidal, R Frangione, B Ghiso, J Pappolla, MA
Citation: B. Poeggeler et al., Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A beta peptide, BIOCHEM, 40(49), 2001, pp. 14995-15001
Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
Authors: Sigurdsson, EM Scholtzova, H Mehta, PD Frangione, B Wisniewski, T
Citation: Em. Sigurdsson et al., Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice, AM J PATH, 159(2), 2001, pp. 439-447
Conformation as therapeutic target in the prionoses and other neurodegenerative conditions
Authors: Wisniewski, T Sigurdsson, EM Aucouturier, P Frangione, B
Citation: T. Wisniewski et al., Conformation as therapeutic target in the prionoses and other neurodegenerative conditions, METH MOL M, 59, 2001, pp. 223-236
Fibrillar amyloid-beta affects neurofibrillary changes but only in neuronsalready involved in neurofibrillary degeneration
Authors: Wegiel, J Bobinski, M Tarnawski, M Dziewiatkowski, J Popovitch, E Miller, DC Wisniewski, T Golomb, J de Leon, MJ Reisberg, B
Citation: J. Wegiel et al., Fibrillar amyloid-beta affects neurofibrillary changes but only in neuronsalready involved in neurofibrillary degeneration, ACT NEUROP, 101(6), 2001, pp. 585-590
Prion diseases and the immune system
Authors: Aucouturier, P Carp, RI Carnaud, C Wisniewski, T
Citation: P. Aucouturier et al., Prion diseases and the immune system, CLIN IMMUNO, 96(2), 2000, pp. 79-85
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides
Authors: Soto, C Kascsak, RJ Saborio, GP Aucouturier, P Wisniewski, T Prelli, F Kascsak, R Mendez, E Harris, DA Ironside, J Tagliavini, F Carp, RI Frangione, B
Citation: C. Soto et al., Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides, LANCET, 355(9199), 2000, pp. 192-197
In vivo reversal of amyloid-beta lesions in rat brain
Authors: Sigurdsson, EM Permanne, B Soto, C Wisniewski, T Frangione, B
Citation: Em. Sigurdsson et al., In vivo reversal of amyloid-beta lesions in rat brain, J NE EXP NE, 59(1), 2000, pp. 11-17
Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E
Authors: Golabek, AA Kida, E Walus, M Perez, C Wisniewski, T Soto, C
Citation: Aa. Golabek et al., Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E, BIOPHYS J, 79(2), 2000, pp. 1008-1015
On the biological activity of vitamin E
Authors: Kayden, HJ Wisniewski, T
Citation: Hj. Kayden et T. Wisniewski, On the biological activity of vitamin E, AM J CLIN N, 72(1), 2000, pp. 201-202
Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt-Jakob disease
Authors: Aucouturier, P Kascsak, RJ Frangione, B Wisniewski, T
Citation: P. Aucouturier et al., Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt-Jakob disease, NEUROSCI L, 274(1), 1999, pp. 33-36
Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations
Authors: Dowjat, WK Wisniewski, T Efthimiopoulos, S Wisniewski, HM
Citation: Wk. Dowjat et al., Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations, NEUROSCI L, 267(2), 1999, pp. 141-144
Optimization case studies in the NEOS Guide
Authors: Czyzyk, J Wisniewski, T Wright, SJ
Citation: J. Czyzyk et al., Optimization case studies in the NEOS Guide, SIAM REV, 41(1), 1999, pp. 148-163
Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders
Authors: Copp, RP Wisniewski, T Hentati, F Larnaout, A Ben Hamida, M Kayden, HJ
Citation: Rp. Copp et al., Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders, BRAIN RES, 822(1-2), 1999, pp. 80-87
Prion diseases and the immune system
Authors: Aucouturier, P Frangione, B Wisniewski, T
Citation: P. Aucouturier et al., Prion diseases and the immune system, ANN MED IN, 150(2), 1999, pp. 75-78
Enrichment of presenilin 1 peptides in the membranes of neuronal vesicles:Implications for Alzheimer's disease
Authors: Efthimiopoulos, S Georgakopoulos, A Floor, E Shioi, J Cui, W Wisniewski, T Robakis, NK
Citation: S. Efthimiopoulos et al., Enrichment of presenilin 1 peptides in the membranes of neuronal vesicles:Implications for Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 201-212
Risultati: 1-17 |